Patient Blood Management Market Future Estimation, Share, Insights and Strategic Analysis 2022-2027

1
Patient Blood Management Market Analysis by
Share, Size, Supply and Demand 2022-2027 The
US11 Bn market for patient blood management
(PBM) is poised for a healthy growth outlook. A
new research study in progress at Fairfield
Market Research suggests that the demand for
proper patient blood management will grow strong
with critically rising need for blood resource
conservation amid the rapidly evolving blood
transfusion space, and disease treatment
delivery. As blood transfusion remains the
backbone of the in-patient care in world of
medicine and healthcare, the need for ensuring
blood availability whenever required along with
effective disease treatment. Get Sample Copy of
Patient Blood Management Market
https//www.fairfieldmarketresearch.com/report/pat
ient-blood-management-market/request-sample Growin
g Inclination toward Blood Resource Preservation
Bodes Well for PBM Market Decreasing rate of
post-operative morbidity remains among the
strongest factors contributing toward the growth
of market. The quality of life of patients
suffering chronic health conditions has also been
improved a lot when compared with the situation
earlier, roughly a decade ago. This also will
play out as a favourable growth factor for
patient blood management market. In addition,
decreased donor exposure to a variety of
infections, and remarkably falling rate of
mortality associated with certain diseases
accompanying high surgical risk further elevate
the growth prospects of patient blood
management. Given the advantages like these and
more, there has been a growing inclination of
several nations toward preserving their blood
resources. While this would potentially be a
means of eliminating the autologous transfusions
wherever possible to eventually bring down the
overall costs associated. This would thus create
a situation where a lesser number of donors would
be required each year. With specific guidelines
by their side, more physicians are thus likely to
register demand for efficient patient blood
management. PBM to Gain Traction in an Effort to
Address Global Anaemia Burden
2
Concerns around anaemia continue to aggravate
worldwide, which also point to poor outcomes for
several other conditions, including kidney
disorders, heart failure, stroke, cancers,
chronic obstructive pulmonary disease (COPD), and
autoimmune disorders. Patient blood management is
being looked at as a potentially viable, and
effective way to avoid unnecessary blood
transfusions, and promote optimum haemoglobin
care, especially targeting chronic disease
patients. There has been a surge in demand for
PBM over the recent past as facilities aim to
minimise intraoperative blood transfusion, reduce
the perioperative blood loss, and optimise
postoperative IV fluid management. This is likely
to remain the prime booster to market
expansion. The Growing Role of Blood Banks Blood
banks are expected to retain the top spot as an
end user of PBM techniques, primarily used for
platelets, followed by red blood cells. As
platelets have a short shelf-life and require to
be transfused within the span of five days after
collection, blood banks continue to generate
demand for effective, and efficient patient blood
management techniques for proper storage, and
transfer to hospitals for transfusion. This
entire process serves a critical role in
preserving platelets in their original form,
thereby avoiding any potential complications that
might appear during or post-transfusion. Blood
banks will this remain a significant factor
driving the developments in patient blood
management market. For More Information of
Patient Blood Management Market
Visit https//www.fairfieldmarketresearch.com/rep
ort/patient-blood- manaaement-market
North America to continue leading the global
market Receiving notable support from
governments, academic research organisations,
universities, private companies, as well as
hospitals and other healthcare facilities, the
PBM landscape has been building up strong
presence across the North American region. The
blood transfusion market here is highly active,
which is likely to receive a push from growing
public awareness regarding safe transfusion
practices, surging need for blood transfusion,
and deepening technology penetration. Ascending
demand for platelets, cord blood stem cells, and
artificial blood substitutes is also projected to
uplift the growth outlook of PBM market in North
America. A number of clinics, and hospitals are
increasingly showcasing interest in adopting
patient blood management tools for safer
transfusion practices under their respective
blood banks.
3
About Us
Fairfield Market Research is a UK-based market
research provider. Fairfield offers a wide
spectrum of services, ranging from customized
reports to consulting solutions. With a strong
European footprint, Fairfield operates globally
and helps businesses navigate through business
cycles, with quick responses and multipronged
approaches. The company values an eye for
insightful take on global matters, ably backed by
a team of exceptionally experienced researchers.
With a strong repository of syndicated market
research reports that are continuously published
updated to ensure the ever-changing needs of
customers are met with absolute
promptness. Contact Fairfield Market
Research London, UK UK 44 (0)20 30025888 USA
(Toll-free) 1 (844) 3829746 Web
https//www.fairfieldmarketresearch.com/ Email
sales_at_fairfieldmarketresearch.com Follow Us
LinkedIn